Project Grant R01DK146456
Award Date 9/1/26
Completion Date 5/31/30
Dollars Obligated $826K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
West Hollywood, CA 90048, USA
Similar Awards
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Southern California $599,437 on August 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to explore the immunomodulatory role of neuroendothelial cells (NECs) in kidney health and disease, with particular focus on lupus nephritis pathogenesis. The project will identify novel molecular and cellular mechanisms underlying lupus nephritis, the most...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Brigham and Women's Hospital $729,120 on March 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a pilot and feasibility randomized controlled trial evaluating dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, in patients with active lupus nephritis. Lupus nephritis is a chronic autoimmune kidney disease that carries a 10–30% risk of end-stage...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Ann & Robert H Lurie Children's Hospital of Chicago $164,580 on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847, Project Grant K08DK147611) to investigate immune-mediated mechanisms of tubulointerstitial injury in childhood nephrotic syndrome. The award funds basic research characterizing how dendritic cells and related inflammatory pathways contribute...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Alabama at Birmingham $158,609 on April 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate resident memory T cells in kidney disease pathology during autoimmunity. The research addresses lupus nephritis, a kidney disease affecting over 50 percent of systemic lupus erythematosus (SLE) patients. The project will identify the...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Rush University Medical Center $749,087 on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate sodium-independent mechanisms of edema in nephrotic syndrome. The project studies the role of circulating angiopoietin-like 4 (ANGPTL4), specifically its C-fragment, as a mediator of skin capillary endothelial permeability in nephrotic...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Icahn School of Medicine at Mount Sinai $816,825 on April 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate how injured podocytes communicate with parietal epithelial cells to drive proliferative glomerulopathy, specifically whether podocyte-derived exosomes mediate this cell-to-cell signaling in rapidly progressive glomerulonephritis. The research uses...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Cedars-Sinai Medical Center $1,515,770 on February 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct mechanistic studies of druggable targets in acute kidney injury progression to chronic kidney disease. The award funds research aimed at switching off a maladaptive repair cell state that drives progression from acute kidney injury (AKI) to chronic kidney...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Children's Hospital of Philadelphia $949,759 on May 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to estimate real-world comparative treatment effectiveness and validate anti-phospholipase A2 receptor antibody (PLA2R-Ab) as a biomarker and surrogate endpoint for long-term clinical outcomes in membranous nephropathy using observational data. The project applies...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Washington University $388,750 on April 23, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate the structural and functional mechanisms of podocin in glomerular membrane organization and kidney disease. The research applies detergent-free, vesicle-based cryo-electron microscopy to determine the full-length structure of podocin at near-atomic resolution...
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded $172,560 to The Trustees of Columbia University in the City of New York on June 1, 2026, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The recipient will conduct research on the role of SAP-positive T cells in lupus nephritis, investigating immune mechanisms that initiate and perpetuate kidney inflammation in lupus. The research uses single-cell RNA sequencing with T-cell...